These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6406026)

  • 1. Pseudomonas aeruginosa exoproducts as pulmonary virulence factors.
    Cash HA; Straus DC; Bass JA
    Can J Microbiol; 1983 Apr; 29(4):448-56. PubMed ID: 6406026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Pseudomonas aeruginosa extracellular enzymes in lung disease.
    Woods DE; Sokol PA
    Clin Invest Med; 1986; 9(2):108-12. PubMed ID: 3089661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody response to Pseudomonas aeruginosa exoproducts in cancer patients.
    Crowe KE; Bass JA; Young VM; Straus DC
    J Clin Microbiol; 1982 Jan; 15(1):115-22. PubMed ID: 6821202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudomonas aeruginosa: biology, mechanisms of virulence, epidemiology.
    Vasil ML
    J Pediatr; 1986 May; 108(5 Pt 2):800-5. PubMed ID: 3009772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The contribution of exoproducts to virulence of Pseudomonas aeruginosa.
    Nicas TI; Iglewski BH
    Can J Microbiol; 1985 Apr; 31(4):387-92. PubMed ID: 2988728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical and genetic aspects of Pseudomonas aeruginosa virulence.
    Lory S; Tai PC
    Curr Top Microbiol Immunol; 1985; 118():53-69. PubMed ID: 2414071
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of Pseudomonas aeruginosa exotoxin A and elastase as virulence factors in acute lung infection.
    Blackwood LL; Stone RM; Iglewski BH; Pennington JE
    Infect Immun; 1983 Jan; 39(1):198-201. PubMed ID: 6401692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reaction of antibody in sera from cystic fibrosis patients with non-toxic forms of Pseudomonas aeruginosa exotoxin A.
    Klinger KW; Shuster CW; Klinger J
    Eur J Clin Microbiol; 1985 Apr; 4(2):201-6. PubMed ID: 3924609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of proteases and exotoxin A in the pathogenicity of Pseudomonas aeruginosa infections.
    Wretlind B; Pavlovskis OR
    Scand J Infect Dis Suppl; 1981; 29():13-9. PubMed ID: 6797058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of exotoxin A of Pseudomonas aeruginosa in acute and chronic experimental renal infection.
    Sharma S; Kaur R; Yadav V; Harjai K; Joshi K
    Jpn J Infect Dis; 2004 Jun; 57(3):119-20. PubMed ID: 15218223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of exotoxin A and elastase in the pathogenicity of Pseudomonas aeruginosa strain PAO experimental mouse burn infection.
    Wretlind B; Björklind A; Pavlovskis OR
    Microb Pathog; 1987 Jun; 2(6):397-404. PubMed ID: 3148812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to proteases and exotoxin A of Pseudomonas aeruginosa in patients with cystic fibrosis: Demonstration by radioimmunoassay.
    Klinger JD; Straus DC; Hilton CB; Bass JA
    J Infect Dis; 1978 Jul; 138(1):49-8. PubMed ID: 98596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigens of Pseudomonas aeruginosa and their use in immunoprophylaxis and immunotherapy.
    Stanislavsky ES; Dmitriev BA; Lányi B; Joó I
    Acta Microbiol Hung; 1985; 32(1):3-37. PubMed ID: 2412389
    [No Abstract]   [Full Text] [Related]  

  • 14. [Significance of Pseudomonas aeruginosa virulence factors for acute and chronic Pseudomonas aeruginosa infections].
    Döring G
    Infection; 1987; 15 Suppl 2():S38-41. PubMed ID: 3112018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined host and specific anti-Pseudomonas-directed therapy for Pseudomonas aeruginosa infections in burned mice: experimental results and theoretic considerations.
    Holder IA; Neely AN
    J Burn Care Rehabil; 1989; 10(2):131-7. PubMed ID: 2496130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The contribution of diffusible toxins of Pseudomonas aeruginosa to the pathogenesis of experimental pyelonephritis.
    Al-Ssum RM; Harris DM
    J Infect; 1982 Jan; 4(1):49-55. PubMed ID: 6821099
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical significance of serum antibody responses to exotoxin A and type-specific lipopolysaccharides in patients with Pseudomonas aeruginosa infections.
    Pollack M; Longfield RN; Karney WW
    Am J Med; 1983 Jun; 74(6):980-7. PubMed ID: 6407308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and level of exotoxin A in proteolytic cell-free cultures of clinical isolates of Pseudomonas aeruginosa collected from hospitals in Riyadh, Saudi Arabia.
    al-Ssum RM
    Microbiologica; 1992 Oct; 15(4):355-9. PubMed ID: 1435349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virulence factors of Pseudomonas aeruginosa.
    Döring G; Maier M; Müller E; Bibi Z; Tümmler B; Kharazmi A
    Antibiot Chemother (1971); 1987; 39():136-48. PubMed ID: 3118780
    [No Abstract]   [Full Text] [Related]  

  • 20. [Significance of Pseudomonas aeruginosa virulence factors in acute and chronic Pseudomonas aeruginosa infections].
    Döring G
    Infection; 1987; 15(1):47-50. PubMed ID: 3106228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.